ADL-5859
| Names | |
|---|---|
| IUPAC name
N,N-Diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
PubChem CID |
|
| UNII | |
| |
| |
| Properties | |
| C24H28N2O3 | |
| Molar mass | 392.499 g·mol−1 |
| Related compounds | |
Related compounds |
ADL-5747 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
ADL-5859, also known as compound 20, is an opioid drug that is selective for the δ-opioid receptor, it is being investigated as an alternative to traditional opioids in pain management.